1. McGrath JS, Scholefield J, Gower J, Pickard R. Increasing research capacity and capability – how can national infrastructure help? BJU Int. 2013 March;111(3):370-1
  1. Halligan S, Wooldrage K, Dadswell E, Kralj-Hans I, von Wagner C, Edwards R, Yao G, Kay C, Burling D, Faiz O, Teare J, Lilford RJ, Morton D, Wardle J, Atkin W; SIGGAR investigators. Computed tomographic colonography versus barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients (SIGGAR): a multicentre randomised trial. Lancet. 2013 Apr 6;381 (9873):1185-93
  1. Atkin W, Dadswell E, Wooldrage K, Kralj-Hans I, von Wagner C, Edwards R, Yao G, Kay C, Burling D, Faiz O, Teare J, Lilford R J, Morton D, Wardle J, Halligan S; SIGGAR investigators. Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial. Lancet. 2013 Apr 6;381 (9873):1194-202
  1. Noble P, Vyas M, Al-Attar A, Durrant S, Scholefield J, Durrant L. High levels of cleaved caspase-3 in colorectal tumour stroma predict good survival. Br J Cancer. 2013 May 28;108 (10):2097-105
  1. Maitra RK, Acheson AG, Gornall C, Scholefield JH, Williams JP, Maxwell-Armstrong CA. Results of laparoscopic colorectal surgery from a national training center. Asian J Surg. 2014 Jan;37(1):1-7
  1. Primrose JN, Perera R, Gray A, Rose P, Fuller A, Corkhill A, George S, Mant D; FACS Trial Investigators. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA. 2014 Jan 15;311(3):263-70
  1. Simpson JA, Bush D, Gruss HJ, Jacobs A, Pediconi C, Scholefield JH. A randomised, controlled, crossover study to investigate the safety and response of IR, 2S-methoxamine hydrochloride (NRL001) on anal function in healthy volunteers. Colorectal Dis. 2014 Mar; 16 Supple 1:5-15
  1. Siproudhis L, Jones D, Shing RN, Walker D, Scholefield JH; Libertas Study Consortium. Libertas: rationale and study design of a multicentre, Phase II, double-blind, randomised, placebo-controlled investigation to evaluate the efficacy, safety and tolerability of locally applied NRL001 in patients with faecal incontinence. Colorectal Dis. 2014 Mar; 16 Suppl 1:59-66
  1. Scholefield JH, Walker D. Faecal incontinence: the ‘Cinderella’ disorder. Colorectal Dis. 2014 Mar; 16 Suppl 1:1-4
  1. Dhadda AS, Bessell EM, Scholefield J, Dickinson P, Zaitoun AM. Mandard Tumour Regression Grade, Perineural Invasion, Circumferential Resection Margin and Post-chemoradiation nodal Status Strongly Predict Outcome in Locally Advanced Rectal Cancer Treated with Preoperative Chemoradiotherapy. Clin Oncol (R Coll Radiol). 2014 Apr: 26(4): 197-202
  1. Rayment SJ, Simpson JA, Eames T, Acheson AG, Dashwood MR, Henry Y, Gruss H, Scholefield JH, Wilson VG. Dual Effects of α2-adrenoceptors in modulating myogenic tone in sheep isolated internal anal sphincter. Neurogastroenterol Motil. 2014 Jun 6
  1. Yong YP, Bhandal N, Scholefield J. How to do a trephine colostomy under spinal anaesthesia. ANZ J Surg. 2014 Nov: 84 (11): 881
  1. Albasri A, Fadhil W, Scholefield J H, Durrant L G, Ilyas M. Nuclear expression of phosphorylated focal adhesion kinase is associated with poor prognosis in human colorector cancer. Anticancer Res. 2014 Aug; 34 (8): 3969-74
  1. Scholefield J, Watson L, Smith D, Greenberg J, Wood M J. Allele-specific silencing of mutant Ataxin-7 in SCA7 patient-derived fibroblasts. Eur J Hum Genet. 2014 Dec; 22 (12): 1396-75
  1. Negm OH, Hamed MR, Schoen RE, Whelan RL, Steele RJ, Scholefield J, Dilnot EM, Shantha Kumara HM, Robertson JF, Sewell HF. Human Blood Autoantibodies in the Detection of Colorectal Cancer. PLos One. 2016 Jul: 11 (7):e0156971
  1. Siproudhis L, Graf W, Emmanuel A, Walker D, Shing RN, Pediconi C, Pilot J, Wexner S, Scholefield J. Libertas: a phase ll placebo-controlled study of NRL001 in patients with faecal incontinence showed an unexpected and sustained placebo response. Int J Colorectal Dis. 2016 Jun: 31 (6):1205-16
  1. Varela MA, Curtis HJ, Douglas AG, Hammond SM, O’Loughlin AJ, Sobrido MJ, Scholefield J, Wood MJ. Transfer of genetic therapy across human populations; molecular targets for increasing patient coverage in repeat expansion diseases. Eur J Hum Genet. 2016 Feb: 24 (2):217-6
  1. Hariharan D, Psaltis E, Scholefield J, Lobo DN. Quality of Life and Medico-Legal Implications Following latrogenic Bile Duct Injuries. World J Surg. 2017 Jan: 41 (1):90-99
  1. Keeler BD, Simpson JA, Ng O, Padmanabhan H, Brookes MJ, Acheson AG; IVICA Trial Group. Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorectal cancer. Br J Surg. 2017 Feb: 104 (3):214-221
  1. Kent C, Bessell EM, Scholefield J, Chappell S, Marsh L, Mills J, Sayers I. Chemoradiotherapy with Brachytherapy or Electron Therapy Boost for Locally Advanced Squamous Cell Carcinoma of the Anus-Reducing the Colostomy Rate. J Gastrointest Cancer. 2017 Mar: 48(1):1-7
  1. Lohsiriwat V, Scholefield JH, Wilson VG, Dashwood MR. Endothelin-1 and its receptors on haemorrhoidal tissue: a potential site for therapeutic intervention. BR J Pharmacol. 2017 Jul: 174 (7):569-579
  1. Geh I, Gollins S, Renehan A, Scholefield J, Goh V, Prezzi D, Moran B, Bower M, Alfa-Wali M, Adams R. Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) – Anal Cancer. Colorectal Dis. 2017 Jul: 19 Suppl 1:82-97
  1. Kahan BC, Koulenti D, Arvaniti K, Beavis V, Campbell D, Chan M, Moreno R, Pearse RM; International Surgical Outcomes Study (ISOS) group. Critical care admission following elective surgery was not associated with survival benefit: prospective analysis of data from 27 countries. Intensive Care Med. 2017 Jul: 43 (7): 971-979 (JHS was a contributing clinician to this trial)